Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Current Protocols|January 30, 2026
Transient Cyclic Structured Oligonucleotide Designs for Therapeutic ApplicationsSudhir AgrawalTrends in Molecular Medicine|September 29, 2020
RNA Therapeutics Are Stepping Out of the MazeSudhir AgrawalBiomedicines|June 2, 2021
The Evolution of Antisense Oligonucleotide Chemistry-A Personal JourneySudhir AgrawalAnnals of the New York Academy of Sciences|January 31, 2004
Modulation of Toll-like Receptor 9 Responses through Synthetic Immunostimulatory Motifs of DNASudhir Agrawal, Ekambar R KandimallaCurrent Protocols in Nucleic Acid Chemistry|April 23, 2008
Chemistry of CpG DNAEkambar R Kandimalla, Sudhir AgrawalNature Biotechnology|December 8, 2004
Role of Toll-like receptors in antisense and siRNA [corrected]Sudhir Agrawal, Ekambar R KandimallaTrends in Molecular Medicine|March 7, 2002
Medicinal chemistry and therapeutic potential of CpG DNASudhir Agrawal, Ekambar R KandimallaImmuno-Oncology Technology|June 27, 2022
Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptorsSudhir Agrawal, Ekambar R KandimallaMethods in Molecular Biology (Clifton, N.J.)|February 25, 2022
Introduction and History of the Chemistry of Nucleic Acids TherapeuticsMichael J Gait, Sudhir AgrawalCurrent Cancer Drug Targets|February 22, 2005
Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanismsRuiwen Zhang, Hui Wang, Sudhir AgrawalPageof 11